Financials
- Market Capitalization 47.4 B
- Employee 883
- Founded 2014
- CEO N/A
- Website www.revmed.com
- Headquarter Delaware, United States
- FIGI BBG00829F4P8
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-13.39
Fiyat/satışlar oranı
—
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 259 | ARGX argenx SE - American Depositary Shares | 1058.90 USD | +1.13% | +2.43% | +21.11% | +50.13% | 65.53 B USD | ||
| 290 | MRNA Moderna, Inc. - Common Stock | 142.77 USD | -4.60% | +7.75% | +159.39% | +488.50% | 57.00 B USD | ||
| 444 | ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 236.56 USD | -1.02% | +3.36% | -17.82% | -47.73% | 31.65 B USD | ||
| 485 | RPRX Royalty Pharma plc - Class A Ordinary Shares | 61.92 USD | +0.19% | +2.30% | +3.36% | +66.18% | 27.65 B USD |